Cerebrospinal fluid somatostatin levels in febrile seizures and epilepsy in children

Neuropeptides

Volumn 34, Issue 1, 2000, Pages 18-24

  Hirai, K ^a   Seki, T ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOSTATIN;

ARTICLE; CHILD; CONTROLLED STUDY; DISEASE CLASSIFICATION; EPILEPSY; EPILEPTOGENESIS; FEBRILE CONVULSION; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NERVE CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; SCHOOL CHILD; SOMATOSTATIN RELEASE;

EID: 0034070921     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1054/npep.1999.0781     Document Type: Article

References (45)

1. Fukuyama Y., Seki T., Ohtsuaka C., Miura H., Hara M. Practical guidelines for physicians in the management of febrile seizures. Brain Dev. 18:1996;479-484
2. Riekkinen P. J., Pitkanen A. Somatostatin and epilepsy. Metabolism. 39:1990;112-115
3. Epilepsia. 30:1989;389-399
4. Hirai K., Seki T., Takuma Y. Cerebrospinal fluid somatostatin in West syndrome: changes in response to combined treatment with high-dose pyridoxal phosphate and low-dose corticotropin. Neuropeptides. 32:1998;581-586
5. Beal M. F., Mazurek M. F., Black P. M., Martin J. B. Human cerebrospinal fluid somatostatin in neurologic disease. J Neurol Science 71:1985;91-104
6. Arimura A., Lundqvist G., Rothman J. Radioimmunoassay of somatostatin. Metabolism. 27:1978;1139-1144
7. Brazeau P., Vale W., Burgus R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science. 179:1973;77-79
8. Kato N., Higuchi T., Friesen H. G., Wada J. A. Changes of immunoreactive somatostatin and β-endorphin content in rat brain after amygdaloid kindling. Life Science 32:1983;2415-2422
9. Sloviter R. S. Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy. Science. 235:1987;73-76
10. Hartikainen P., Soininen H., Reinkainen K. J., Sirvio J., Soikkeli R., Riekkinen P. J. Neurotransmitter markers in the cerebrospinal fluid of normal subjects. Effects of aging and other confounding factors. J Neural Transm Gen Sect. 84:1991;103-117
11. Maeda K., Yasuda M., Kaneda H., Maeda S., Yamadori A. Cerebrospinal fluid (CSF) neuropeptide Y- and somatostatin-like immunoreactivities in man. Neuropeptides. 27:1994;323-332
12. Patel Y. C., Rao K., Reichlin S. Somatostatin in human cerebrospinal fluid. N Engl J Med. 296:1977;529-533
13. Jolkkonen J., Kahkonen K., Pitkanen A. Cholinergic deafferentation exacerbates seizure-induced loss of somatostatin-immunoreactive neurons in the rat hippocampus. Neuroscience. 80:1997;401-411
14. Jolkkonen J., Jolkkonen E., Pitkanen A. Seizure-induced damage to somatostatin-immunoreactive neurons in the rat hippocampus is regulated by fimbria-fornix transection. Exp Neurol. 145:1997;141-153
15. Mitchell J., Cook I., Hervey V. Effect of seizures on hippocampal peptidergic neurons. Neuropathol Appl Neurobiol. 23:1997;299-306
16. Tuunanen J., Halonen T., Pitkanen A. Decrease in somatostatin-immunoreactive neurons in the rat amygdaloid complex in a kindling model of temporal lobe epilepsy. Epilepsy Res. 26:1997;315-327
17. Buckmaster P. S., Dudek F. E. Neuron loss, granule cell axon reorganization, and functional changes in the dentate gyrus of epileptic kainate-treated rats. J Comp Neurol. 385:1997;385-404
18. Mathern G. W., Babb T. L., Pretorius J. K., Leite J. P. Reactive synaptogenesis and neuron densities for neuropeptide Y, somatostatin, and glutamate decarboxylase immunoreactivity in the epileptogenic human fascia dentata. J NeuroScience 15:1995;3990-4004
19. Robbins R. J., Brines M. L., Kim J. H. A selective loss of somatostatin in the hippocampus of patients with temporal lobe epilepsy. Ann Neurol. 29:1991;325-332
20. Strowbridge B. W., Bean A. J., Spencer D. D., Roth R. H., Shepherd G. M., Robbins R. J. Low levels of somatostatin-like immunoreactivity in neocortex resected from presumed seizure foci in epileptic patients. Brain Res. 587:1992;164-168
21. Kohler J., Schroter E., Cramer H. Somatostatin-like immunoreactivity in the cerebrospinal fluid of neurological patients. Arch Psychiatr Nervenkr. 231:1982;503-508
22. Pitkanen A., Jolkkonen J., Honkanen K. L., Riekkinen P. Effect of pentylenetetrazol-induced convulsions on somatostatin-like immunoreactivity in rat cerebrospinal fluid. Neuropeptides. 9:1987;19-24
23. Pitkanen A., Tuunanen J., Kalviainen R., Partanen K., Salmenpera T. Amygdala damage in experimental and human temporal lobe epilepsy. Epilepsy Res. 32:1998;233-253
24. Dalby N. O., Tonder N., Wolby D. P. D., West M., Finsen B., Bolwig T. G. No loss of hippocampal hilar somatostatinergic neurons after repeated electroconvulsive shock: a combined stereological and in situ hybridization study. Biol Psychiatry. 40:1996;54-60
25. de Lanerolle N. C., Kim J. H., Robbins R. J., Spencer D. D. Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy. Brain Res. 495:1989;387-395
26. Nagaki S., Fukuyama Y., Kato N. Immunoreactive somatostatin contents in the cerebrospinal fluid of children with various types of epilepsy. Jpn J Psychiatr Neurol. 42:1988;651-652
27. Nagaki S., Nagaki S., Minatogawa Y. The role of vasopressin, somatostatin and GABA in febrile convulsion in rat pups. Life Science 58:1996;2233-2242
28. Cramer H., Heitzelmann K. M. Somatostatin in cerebrospinal fluid after generalized convulsions or cerebral infarction in humans. J Neurol Neurosurg Psychiatry. 53:1990;1015-1016
29. Simonato M., Bregola G., Beani L. Time- and region-specific variations in somatostatin release following amygdala kindling in the rat. J Neurochem. 70:1998;252-259
30. Devinsky O., Emoto S., Nadi N. S., Theodore W. H. Cerebrospinal fluid levels of neuropeptides, cortisol, and amino acids in patients with epilepsy. Epilepsia. 34:1993;255-261
31. Lang S., Peigen K., Liu J., Zhang F., Chen X., Liu Z. Somatostatin concentrations in cerebrospinal fluid and brain tissue of patients with refractory epilepsy. Mol Chem Neuropathol. 17:1992;239-247
32. Geola F. L., Yamada T., Warwick R. J., Tourtelotte W. W., Hershman J. M. Regional distribution of somatostatin-like immunoreactivity in the human brain. Brain Res. 229:1981;35-42
33. Rissler K., Jost S., Mohadjer M., Mundinger F., Cramer H. Molecular size distribution of somatostatin-like immunoreactivity in the cerebroventricular fluid of neurosurgical patients. Neurosci Res. 4:1987;343-356
34. Pitkanen A., Jolkkonen J., Riekkinen P. β -endorphin, somatostatin, and prolactin levels in cerebrospinal fluid of epileptic patients after generalized convulsion. J Neurol Neurosurg Psychiatry. 50:1987;1294-1297
35. Franco-Bourland R. E. Vasopressinergic, oxytocinergic, and somatostatinergic neuronal activity after adrenalectomy and immobilization stress. Neurochem Res. 23:1998;695-701
36. Nakamura H., Moroji T., Nagase H., Okazawa T., Okada A. Changes of cerebral vasoactive intestinal polypeptide- and somatostatin-like immunoreactivity induced by noise and whole-body vibration in the rat. Eur J Appl Physiol. 68:1994;62-67
37. Bremner J. D., Licinio J., Darnell A. Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry. 154:1997;624-629
38. Pitkanen A., Lepola U., Ylinen A., Riekkinen P. J. Somatostatin and β -endorphin levels in cerebrospinal fluid of nonmedicated and medicated patients with epileptic seizures. Neuropeptides. 13:1989;9-15
39. Pitkanen A., Tuunanen J., Halonen T. Vigabatrin and carbamazepine have different efficacies in the prevention of status epilepticus induced neuronal damage in the hippocampus and amygdala. Epilepsy Res. 24:1996;29-45
40. Richardson S. B., Twente S. Anticonvulsants inhibit rat neuronal somatostatin release. Brain Res. 571:1992;230-234
41. Reichlin S., Mothon S. Carbamazepine and phenytoin inhibit somatostatin release from dispersed cerebral cells in culture. Ann Neurol. 29:1991;413-417
42. Steardo L., Barone P., Hunnicutt E. Carbamazepine lowering effect on CSF somatostatin-like immunoreactivity in temporal lobe epileptics. Acta Neurol Scand. 74:1986;140-144
43. Riekkinen P. J., Pitkanen A., Ylinen A., Sivenius J., Halonen T. Specificity of vigabatrin for the GABAergic system in human epilepsy. Epilepsia. 30(Suppl 3):1989;S18-S22
44. Halonen T., Nissinen J., Jansen J. A., Pitkanen A. Tiagabine prevents seizures, neuronal damage and memory impairment in experimental status epileptics. Eur J Pharmacol. 299:1996;69-81
45. Pitkanen A., Hyttinen J. M., Sirvio J., Jolkkonen J., Sarlund H., Riekkinen P. The levels of somatostatin in the brain and CSF of rat after carbamazepine administration. Pharmacol Toxicol. 64:1989;266-271